Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 310.5469
- Book/Share 57.6123
- PB 1.3369
- Debt/Equity 1.121
- CurrentRatio 0.8319
- ROIC 0.0043
- MktCap 97530497823.0
- FreeCF/Share 4.959
- PFCF 15.4983
- PE 207.8833
- Debt/Assets 0.3202
- DivYield 0.0346
- ROE 0.0062
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Neutral
CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
Read More
CVS Health: Exploit The Sector Panic Ahead Of Earnings
Published: February 03, 2026 by: Seeking Alpha
Sentiment: Negative
CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth's outlook. CVS's early restructuring, cost cuts, and reduced Medicare exposure have prepared it better than peers for current industry headwinds. At 10–11x forward earnings, CVS trades at a discount to peers, with potential for multiple expansion if execution continues.
Read More
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
UNH Stock vs. CVS
Published: January 15, 2026 by: Forbes
Sentiment: Negative
UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of 6%, combined with a moderate valuation, as reflected by a PE of 17.2 in contrast to CVS's 218.3.
Read More
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
Published: January 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: January 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health to hold fourth quarter and full year 2025 earnings conference call
Published: January 09, 2026 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.
Read More
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Published: December 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.
Read More
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Codoxo's Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America's Largest Health Plans
Published: December 17, 2025 by: Business Wire
Sentiment: Neutral
DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round as a new investor, with continued investment from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (venture arm of Blue Cross and Blue Shield of Alabama) and QED Investors. This milestone brings Codoxo's to.
Read More
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents
Published: December 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: December 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Published: December 11, 2025 by: PRNewsWire
Sentiment: Neutral
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I. , Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents.
Read More
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
Published: December 10, 2025 by: Seeking Alpha
Sentiment: Neutral
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
Read More
Buy Or Fear CVS Stock At $78?
Published: December 10, 2025 by: Forbes
Sentiment: Neutral
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits and elevated debt still render the stock a “cheap but risky” option, rather than a definitive bargain.
Read More
CVS Health: Investor Day Targets Set Attractive Baseline For 2026
Published: December 09, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health is positioned for continued outperformance, with a strong turnaround driving industry-leading results and a reiterated "Buy" rating. CVS's Q3 showed 7.8% revenue growth, 47% adjusted EPS growth, and significant margin improvement, reversing prior underperformance versus peers. Investor Day guidance signals robust EPS growth through 2028, led by Healthcare Benefits and a focus on profitability over aggressive expansion.
Read More
CVS Investor Day Highlights Major Growth Ahead - Bullish Chart Into 2026
Published: December 09, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is a top S&P 500 performer in 2025, up 78% YTD, with strong operational and financial momentum. I reiterate a Buy rating for CVS, raising my intrinsic value target to $93, based on 2026 EPS guidance and a 13x multiple. Management projects mid-teen EPS growth, robust cash flow, and improved margins across all business segments through 2028.
Read More
CVS Health updated its 2025 guidance again, and the stock is rallying
Published: December 09, 2025 by: Market Watch
Sentiment: Positive
CVS Health's stock was up about 4% at the market open on Tuesday after the company boosted its revenue and profit guidance for the year and detailed its full-year expectations for 2026.
Read More
CVS Health lifts full-year guidance during investor event
Published: December 09, 2025 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) shares moved higher on Tuesday after raising its full-year 2025 financial guidance during its Investor Day event, reflecting stronger performance across its health care businesses. The company now expects 2025 revenue of at least $400 billion, up from a prior forecast of $397.3 billion.
Read More
CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States
Published: December 05, 2025 by: PRNewsWire
Sentiment: Neutral
New report highlights the company's role as a top U.S. employer, investing in improving health and supporting local communities WOONSOCKET, R.I. , Dec. 5, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released its inaugural National Economic Impact Report demonstrating the positive economic impact that the company has in communities across the country.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Why Is CVS Health (CVS) Up 4.1% Since Last Earnings Report?
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner
- Employees 219000